• CoronaCoronavirus (COVID-19) Resources

    In an effort to support our members with the most updated information on COVID-19 we developed this resource page to easily access current CDC information and other resources to assist you professionally and personally.

    We will continue to update this page with more information as it becomes available and welcome your input as we navigate through this situation. As health care professionals it is our job to educate our patients and families on prevention and the what to do if someone is symptomatic.

    View resources

     

  • Clinical Care OptionsNew for GAPNA members: Clinical Care Options

    GAPNA has partnered with a Clinical Care Options to offer an ongoing series of free CNE programs available to GAPNA members. "Vaccinations and Healthy Aging: Protecting Your Older Patients From Shingles" is the latest program offered.

    In this live webinar, expert faculty expert faculty discuss how important it is to prevent shingles in older patients.

    Find out about it!

  • GAPNA 2020 National President Deborah Dunn, EdD, MSN, GNP-BC, ACNS-BC, GS-C interviews Dr. Ron Billano Ordona, DNP, FNP-BC about providing home-based primary care during COVID 19.

    "Facing Forward: Providing Home-based Primary Care during COVID 19"


    View the Video

Lonhala Magnair

Current Strategic Partners

GAPNA is a name chosen to reflect the diversity of our current and potential members, all who are interested in providing the highest quality of care to older adults.

We are the only advanced practice nursing organization that focuses on older adults, the fastest growing segment of the population.

View complete details about the GAPNA Strategic Partners Program.

If you would like to discuss your involvement and more details, please contact Jack Edelman, Director of Marketing, at 856-256-2313, Jack.Edelman@ajj.com or Heidi Perret, Marketing Coordinator, at 856-256-2375, heidi.perret@ajj.com.

GAPNA thanks our current Strategic Partners for their support of our organization.

  

AcadiaACADIA

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders.

Corporate Headquarters
ACADIA Pharmaceuticals
3611 Valley Centre Drive, Suite 300
San Diego, CA  92130
www.acadia-pharm.com


AvanirAvanir

Avanir Pharmaceuticals is a pharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need.

Corporate Headquarters
Avanir Pharmaceuticals
30 Enterprise, Suite 400
Aliso Viejo, CA 92656
Phone: 949-3889-6700


NeurocrineNeurocrine

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with more than 25 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.

The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia and endometriosis* and clinical development programs in multiple therapeutic areas including Parkinson’s disease, congenital adrenal hyperplasia and uterine fibroids*.

Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie).

Corporate Headquarters
Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego, CA 92130
Phone: 1-858-617-7600
For more information, visit neurocrine.com, and follow the company on LinkedIn. (*in collaboration with AbbVie)


SK Life ScienceSK Life Science

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals, Co., Ltd., is focused on developing and commercializing treatments for disorders of the central nervous system (CNS). Both are a part of the global conglomerate SK Group, the second largest company in Korea. SK life science is located in Paramus, New Jersey.

We have a pipeline of eight compounds in development for the treatment of CNS disorders including epilepsy, Lennox‐Gastaux syndrome and attention deficit hyperactivity disorder, among others. The first product the company is planning to commercialize independently is cenobamate (YKP3089), an investigational compound for the potential treatment of partial‐onset seizures in adult patients.

For more information, visit their websites listed below.

Corporate Headquarters
SK Life Science
461 From Road, 5th Floor
Paramus, NJ 07652
Websites: SK life scienceSK Biopharmaceuticals.